Literature DB >> 20022887

Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy.

Christian M Simon1, Sibylle Jablonka, Rocio Ruiz, Lucia Tabares, Michael Sendtner.   

Abstract

Proximal spinal muscular atrophy (SMA) is caused by homozygous loss or mutation of the SMN1 gene on human chromosome 5. Depending on the levels of SMN protein produced from a second SMN gene (SMN2), different forms of the disease are distinguished. In patients with milder forms of the disease, type III or type IV SMA that normally reach adulthood, enlargement of motor units is regularly observed. However, the underlying mechanisms are not understood. Smn(+/-) mice, a mouse model of type III/IV SMA, reveal progressive loss of motor neurons and denervation of motor endplates starting at 4 weeks of age. Loss of spinal motor neurons between 1 month and 12 months reaches 40%, whereas muscle strength is not reduced. In these animals, amplitude of single motor unit action potentials in the gastrocnemic muscle is increased more than 2-fold. Confocal analysis reveals pronounced sprouting of innervating motor axons. As ciliary neurotrophic factor (CNTF) is highly expressed in Schwann cells, we investigated its role for a compensatory sprouting response and maintenance of muscle strength in this mouse model. Genetic ablation of CNTF results in reduced sprouting and decline of muscle strength in Smn(+/-) mice. These findings indicate that CNTF is necessary for a sprouting response and thus enhances the size of motor units in skeletal muscles of Smn(+/-) mice. This compensatory mechanism could guide the way to new therapies for this motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022887     DOI: 10.1093/hmg/ddp562

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

1.  IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.

Authors:  Michela Murdocca; Arianna Malgieri; Andrea Luchetti; Luciano Saieva; Gabriella Dobrowolny; Elvira de Leonibus; Antonio Filareto; Maria Chiara Quitadamo; Giuseppe Novelli; Antonio Musarò; Federica Sangiuolo
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

Review 2.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis.

Authors:  Lyndsay Murray; Thomas H Gillingwater; Rashmi Kothary
Journal:  J Vis Exp       Date:  2014-01-11       Impact factor: 1.355

Review 4.  The therapeutic potential of IGF-I in skeletal muscle repair.

Authors:  Yao-Hua Song; Jenny L Song; Patrice Delafontaine; Michael P Godard
Journal:  Trends Endocrinol Metab       Date:  2013-04-27       Impact factor: 12.015

5.  The HERC1 E3 Ubiquitin Ligase is essential for normal development and for neurotransmission at the mouse neuromuscular junction.

Authors:  S Bachiller; T Rybkina; E Porras-García; E Pérez-Villegas; L Tabares; J A Armengol; A M Carrión; R Ruiz
Journal:  Cell Mol Life Sci       Date:  2015-03-08       Impact factor: 9.261

6.  Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents.

Authors:  Ali Saleh; Subir K Roy Chowdhury; Darrell R Smith; Savitha Balakrishnan; Lori Tessler; Corina Martens; Dwane Morrow; Emily Schartner; Katie E Frizzi; Nigel A Calcutt; Paul Fernyhough
Journal:  Neuropharmacology       Date:  2012-09-26       Impact factor: 5.250

7.  Neuronal activity and axonal sprouting differentially regulate CNTF and CNTF receptor complex in the rat supraoptic nucleus.

Authors:  Jason M Askvig; Laura J Leiphon; John A Watt
Journal:  Exp Neurol       Date:  2011-10-19       Impact factor: 5.330

Review 8.  Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease.

Authors:  Sibylle Jablonka; Benjamin Dombert; Esther Asan; Michael Sendtner
Journal:  J Anat       Date:  2013-09-06       Impact factor: 2.610

9.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

10.  Neurotransmitter release in motor nerve terminals of a mouse model of mild spinal muscular atrophy.

Authors:  Rocío Ruiz; Lucía Tabares
Journal:  J Anat       Date:  2013-03-13       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.